To further examine whether LMO1 is an independent predictor of patient survival, we investigated the relationship between LMO1 mRNA expression and other clinicopathological features of the disease by multivariate analysis in two datasets, the above-mentioned MDACC dataset and the Director’s Challenge Adenocarcinoma Lung Study dataset [23, 24]. This evidence concerns the gene LMO1 and adenocarcinoma.